Exelixis
EXEL
#1305
Rank
A$24.43 B
Marketcap
A$98.63
Share price
4.82%
Change (1 day)
67.01%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company